Wednesday, February 10, 2010, 4:28pm SGT - The Singapore stock market closes in 32 minutes.
To create a watchlist or portfolio of shares, Register
FINANCE HOME PAGEINVESTINGFINANCE NEWS
    Market:       |  

Vanda Pharmaceuticals, Inc. (VNDA)

At 5:00AM SGT: 10.60 USD   0.00 (0.00%)  
 MORE ON VNDA 
Quotes
HereSummary
Charts
News & Info
Company
Analyst Coverage
Ownership
Financials
 Vanda Pharmaceuticals Inc. (NGM:VNDA) Delayed quote dataEdit
Last Trade:10.60 USD
Trade Time:5:00AM SGT
Change: 0.00 (0.00%)
Prev Close:10.60
Open:N/A
Bid:N/A
Ask:N/A
1y Target Est:22.00
Day's Range:N/A - N/A
52wk Range:0.60 - 16.65
Volume:0
Avg Vol (3m):461,687
Market Cap:288.33M
P/E (ttm):N/A
EPS (ttm):-1.27
Div & Yield:N/A (N/A%)
[Chart]
1d  5d  3m  6m  1y  2y  5y 
Use Y! Toolbar to track stocks
 Add VNDA to Portfolio   Download Data

 HEADLINES 
•Vanda Pharmaceuticals to Announce Fourth Quarter and Full Year 2009 Financial Results on February 16, 2010
PR Newswire (Wed 3:09am)
•These Stocks Can Easily Double Your Money
at Motley Fool (Thu, Jan 21)
•Competitive Schizophrenia Market
Zacks.com (Wed, Jan 13)
•VANDA PHARMACEUTICALS INC. Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Ex
EDGAR Online (Tue, Jan 12)
•Drug News: Impotence, Arthritis and Schizophrenia
at The Wall Street Journal Online (Tue, Jan 12)
•Sales start for Vanda Pharmaceuticals schizophrenia treatment
at bizjournals.com (Tue, Jan 12)
•Fanapt(TM) Launches in the U.S.
PR Newswire (Mon, Jan 11)
•Biotech's Movers and Shakers 2009: BioBuzz
at TheStreet.com (Mon, Jan 4)
•Biotech's Movers & Shakers 2009: BioBuzz
at TheStreet.com (Mon, Jan 4)
•Biotech's 2009 Movers & Shakers: BioBuzz
at TheStreet.com (Mon, Jan 4)
•Nasdaq 2009 Winners & Losers
at TheStreet.com (Fri, Jan 1)
•Millennial Stocks - Up By Over 1,000% In 2009
at Investopedia (Fri, Jan 1)
More Headlines for VNDA...
 ANALYST 
EPS Est (next year) (Dec-09) :-1.14
EPS Est (in 2 years) (Dec-10) :-0.31
Avg Rec (current)*:1.0
PEG Ratio:N/A
* (Strong Buy) 1.0 - 5.0 (Strong Sell)
Analyst Opinion - Estimates

 BUSINESS SUMMARY 
Vanda Pharmaceuticals Inc., a biopharmaceutical company, engages in the development and commercialization of clinical-stage drug candidates for central nervous system disorders.

Full Company Profile



Add to My Portfolio Add to Portfolio    Email to a Friend Email to a Friend
Get Summary for Another Symbol:
Search by Company
•Latest News•Singapore Indices